Rifampicin 600mg

DRUG2 trials

Sponsors

Dong-A ST Co., Ltd., Gates Medical Research Institute

Conditions

HealthyHealthy Adult Participants

Phase 1

Evaluate the Effect of Clarithromycin/Rifampicin on the Pharmacokinetics of DA-8010 in Healthy Adults

CompletedNCT05991401

Dong-A ST Co., Ltd.Healthy

Start: 2023-08-18End: 2023-11-17Updated: 2024-01-25

A Phase 1 Multiple Dose Trial in Healthy Adult Participants to Evaluate the Safety, Tolerability, Drug-Drug Interactions, and Pharmacokinetics of TBD11

RecruitingNCT07883226

Gates Medical Research InstituteHealthy Adult Participants

Start: 2026-10-21End: 2027-05-30Target: 66Updated: 2026-10-22